These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 36176475)

  • 1. Gut microbiota is a potential goalkeeper of dyslipidemia.
    Lei L; Zhao N; Zhang L; Chen J; Liu X; Piao S
    Front Endocrinol (Lausanne); 2022; 13():950826. PubMed ID: 36176475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary lipids, gut microbiota and lipid metabolism.
    Schoeler M; Caesar R
    Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligustrum robustum Alleviates Atherosclerosis by Decreasing Serum TMAO, Modulating Gut Microbiota, and Decreasing Bile Acid and Cholesterol Absorption in Mice.
    Liu S; He F; Zheng T; Wan S; Chen J; Yang F; Xu X; Pei X
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100014. PubMed ID: 34005835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms.
    Liu S; He Y; Zhang Y; Zhang Z; Huang K; Deng L; Liao B; Zhong Y; Feng J
    Gut Microbes; 2023 Dec; 15(2):2290331. PubMed ID: 38073096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites.
    Zhang W; Dong XY; Huang R
    Transl Stroke Res; 2023 Dec; 14(6):811-828. PubMed ID: 36279071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.
    Vourakis M; Mayer G; Rousseau G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
    Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
    Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases.
    Yntema T; Koonen DPY; Kuipers F
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on gut microbiota in cardiovascular diseases.
    Qian B; Zhang K; Li Y; Sun K
    Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
    Duttaroy AK
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
    Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
    Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
    Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease.
    Busnelli M; Manzini S; Chiesa G
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31892152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of gut microbiota and metabolites in overweight and obesity of children.
    Zhang S; Dang Y
    Front Endocrinol (Lausanne); 2022; 13():994930. PubMed ID: 36157438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.